Zevra Therapeutics (ZVRA) Common Equity (2014 - 2026)
Zevra Therapeutics (ZVRA) posted Common Equity of $238.92 million for Q3 2026, up 79.4% from $133.17 million a year earlier and up 9.8% from the prior quarter.
Powered by 
Analysis
Zevra Therapeutics (ZVRA) Common Equity (2014 - 2026) Analysis & Trends
At the end of FY2025, Zevra Therapeutics' Common Equity came in at $154.66 million, up 289.9% from FY2024.
- In prior years, Zevra Therapeutics' Common Equity was $39.67 million in FY2024 (-35.9%), $61.86 million in FY2023 (-17.6%), $75.12 million in FY2022 (-26.1%) and $101.66 million in FY2021.
- The Q3 2026 figure stands as the highest quarterly Common Equity in data going back to Q4 2014.
- On a year-over-year basis, Common Equity has increased in each of the last six quarters, with growth averaging 144.6% over the last eight quarters.
- The strongest year-over-year quarter for Common Equity in the past five years was Q1 2026, with growth of 401.7%; the weakest was Q1 2023, with a decline of 51.2%.
- According to Business Quant data, Common Equity for the three prior quarters was $217.65 million (Q2 2026), $205.8 million (Q1 2026) and $154.66 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 40.27 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 81.53 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | -4.58 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 44.95 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 51.81 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 14.35 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 13.04 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 89.30 Bn |
| 10 | Zevra Therapeutics | 708.52 Mn | -100.24 Mn | 36.01 Mn | 238.92 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 238.92 Mn |
| Jun 30, 2026 | 217.65 Mn |
| Mar 31, 2026 | 205.80 Mn |
| Dec 31, 2025 | 154.66 Mn |
| Sep 30, 2025 | 133.17 Mn |
| Jun 30, 2025 | 117.23 Mn |
| Mar 31, 2025 | 41.02 Mn |
| Dec 31, 2024 | 39.67 Mn |
| Sep 30, 2024 | 69.77 Mn |
| Jun 30, 2024 | 32.48 Mn |
| Mar 31, 2024 | 48.82 Mn |
| Dec 31, 2023 | 61.86 Mn |
| Sep 30, 2023 | 61.52 Mn |
| Jun 30, 2023 | 58.87 Mn |
| Mar 31, 2023 | 59.27 Mn |
| Dec 31, 2022 | 75.12 Mn |
| Sep 30, 2022 | 93.79 Mn |
| Jun 30, 2022 | 99.23 Mn |
| Mar 31, 2022 | 121.50 Mn |
| Dec 31, 2021 | 101.66 Mn |
API Access
Zevra Therapeutics Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=ZVRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "ZVRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=ZVRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();